NCT05272072

Brief Summary

Due to the aging of populations, hip fracture operations are increasing from year to year. This operations have many complications also high morbidity and the mortality. Population of this study is oldest old age patients who will have an operation because of hip fracture. The primary outcome of this study is evaluation of relationship between preoperative fibrinogen/albumin ratio and the morbidity after hip fracture operations. The secondary outcomes of this study is evaluation of relationships between fibrinogen/albumin ratio and mortality, length of stay in ICU, length of stay in hospital, postoperative complications, blood product consumption. The study will be completed after the records of preoperative, intraoperative data and the data of the first 30 days postoperatively in this population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2022

Completed
26 days until next milestone

First Posted

Study publicly available on registry

March 9, 2022

Completed
21 days until next milestone

Study Start

First participant enrolled

March 30, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 21, 2023

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

March 2, 2023

Status Verified

March 1, 2023

Enrollment Period

11 months

First QC Date

February 11, 2022

Last Update Submit

March 1, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Morbidity

    Age Adjusted Charlson Comorbidity Index will be calculated for morbidity estimation. This score predicts the ten-year mortality for a patient who may have a range of comorbid conditions. The minimum score is 4 for oldest old patients. The maximum score is 34. Higher scores mean a worse outcome.

    Preoperative (before induction of anesthesia)

Secondary Outcomes (7)

  • Nottingham Hip Fracture Score

    Preoperative (before induction of anesthesia)

  • Clinical Frailty Scale Score

    Preoperative (before induction of anesthesia)

  • Mortality

    Up to 30 days

  • Length of stay in ICU

    Up to 30 days

  • Length of stay in hospital

    Up to 30 days

  • +2 more secondary outcomes

Eligibility Criteria

Age85 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients over 85 years of age who will undergo hip fracture surgery, whose preoperative albumin/fibrinogen ratio is checked

You may qualify if:

  • ≥85 years old patients
  • Primary operation
  • Undergoing hip fracture surgery
  • Receiving consent from patients or guardians that they accept regional anesthesia
  • Not having active infection
  • American Society of Anesthesiologists (ASA) 1-4
  • BMI\< 40 kg/m²

You may not qualify if:

  • Refusal regional anesthesia
  • Infection on regional anesthesia application area
  • Infection in the central nervous system
  • Coagulopathy
  • Known allergy against local anesthetics
  • Severe hepatic insufficiency
  • Haematologic disease
  • Rheumatological disease
  • Autoimmune disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University

Istanbul, Fatih, 34093, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • Emine Dizem Sunal, MD

    Istanbul University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, M.D.

Study Record Dates

First Submitted

February 11, 2022

First Posted

March 9, 2022

Study Start

March 30, 2022

Primary Completion

February 21, 2023

Study Completion

March 1, 2023

Last Updated

March 2, 2023

Record last verified: 2023-03

Locations